spacer gif spacer gif spacer gif spacer gif spacer gif
 QUICK SEARCH:   [advanced]


spacer gif
     Home     Help     Feedback     Subscriptions     Archive     Search     Table of Contents    


Right arrow Help viewing high resolution images
Right arrow Return to article
(Downloading may take up to 30 seconds.
If the slide opens in your browser, select File -> Save As to save it.)

Click on image to view larger version.



Fig. 7. Association of MAGI-3 with tyrosine-phosphorylated proteins. (A) SF763T cells treated with (+) or without (-) vanadate were immunoprecipitated using antibodies to MAGI-3 (MAGI-3 or M23), preimmune serum (PI) or anti-phosphotyrosine (PY). The immunocomplexes were separated on SDS gels and immunoblotted with anti-MAGI-3 (upper panel) or anti-phosphotyrosine (lower panel) antibodies, as indicated. The immunocomplexes from one set of samples were treated with alkaline phosphatase (MAGI-3 + AP) before immunoblotting. MAGI-3 was neither detected by anti-phosphotyrosine after immunoprecipitation with an anti-MAGI-3 antibody nor by anti-MAGI-3 immunoblotting after immunoprecipitation with anti-phosphotyrosine antibodies. The location of molecular weight markers is shown in kDa. (B) MAGI-3 is associated with different tyrosine-phosphorylated proteins in several cell lines. MAGI-3 was immunoprecipitated from untreated (-) or vanadate-treated (+) SF763T and C6 glioblastoma cells or Caco2 colon carcinoma cells, followed by immunoblotting with anti-phosphotyrosine (lower panel) or anti-MAGI-3 (upper panel) antibodies.





Right arrow Return to article